VRDN FY 2014 Earnings — Viridian Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

VRDNViridian Therapeutics, Inc.

$2B

FY 2014 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$4M+0.1% YoY

Gross Profit

$1M24.9% margin

Operating Income

-$7M-159.0% margin

Net Income

-$8M-182.6% margin

EPS (Diluted)

$-52.46

Cash Flow

Operating Cash Flow

-$2M

Free Cash Flow

-$2M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$8M

Total Liabilities

$2M

Stockholders' Equity

$6M

Cash & Equivalents

$5M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4M	$4M	+0.1%
Gross Profit	$1M	$2M	-40.7%
Operating Income	-$7M	-$196,213	-3399.8%
Net Income	-$8M	-$2M	-265.3%